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Parvovirus B19 infection is often asymptomatic, but clinical expressions may include tran-
sient  aplastic crisis, erythema infectiosum, non-immune hydrops fetalis, and chronic red
cell  aplasia. This virus has also been associated with rheumatoid arthritis and other autoim-
mune  connective tissue diseases; however, we could not identify any acute adult myositis
case  developed after a Parvovirus B19 infection in the literature. For this reason, we  would
like to present a rare case of acute myositis developed after Parvovirus B19 infection. In
patients presenting with symptoms of fever, rash on the legs and myositis, viral infections
such as Parvovirus B19 should be kept in mind.
© 2014 Elsevier Editora Ltda. All rights reserved.
Infecc¸ão  por  parvovírus  B19  como  causa  de  miosite  aguda  em  um  adulto
alavras-chave:
arvovírus B19
iosite aguda do adulto
ebre
r  e  s  u  m  o
A infecc¸ão pelo Parvovírus B19 costuma ser assintomática, mas  as expressões clínicas
podem incluir crise aplástica transitória, eritema infeccioso, hidropisia fetal não imune e
aplasia crônica da série vermelha. Esse vírus também se associa à artrite reumatoide e a
outras doenc¸as autoimunes do tecido conjuntivo; entretanto, não conseguimos identiﬁcar
na  literatura nenhum caso de miosite aguda em adulto desenvolvida depois de infecc¸ão pelo
Parvovírus B19. Por essa razão, gostaríamos de apresentar um caso raro de miosite agudadesenvolvida depois de infecc¸ão pelo Parvovírus B19. Nos pacientes que apresentam sin-
tomas de febre, rash nas pernas e miosite, devem ser consideradas as infecc¸ões virais, como
a  causada pelo Parvovírus B19.
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Introduction
Parvovirus B19 (B19), a non-enveloped 22–26 nm icosahedral
single-stranded DNA virus discovered in 1975, is the only
member of the family Parvoviridae known to be pathogenic
to humans.1 This infectious disease is generally seen during
childhood, but rarely in adults. Infection appears to con-
fer lifelong immunity in immunocompetent hosts. Although
the seroprevalence is high, viremia or presence of viral DNA
in peripheral blood is rare in healthy individuals.2 B19 is
transmitted through the respiratory route, but can also be
transmitted vertically from mother to fetus, through bone
marrow and organ transplantations, and via transfused blood
products.2 Most cases of B19 infections are asymptomatic and
resolve spontaneously in adults. But sometimes B19 causes a
transient aplastic crisis, erythema-infectiosum (ﬁfth disease),
non-immune hydrops fetalis and chronic red cell aplasia. This
virus has also been associated with rheumatoid arthritis and
other autoimmune connective tissue diseases;3 however, we
could not identify any acute adult myositis cases developed
after B19 infection. In the literature, for that reason, we would
like to present a rare case of acute myositis developed after
B19 infection.
Case  report
A 38-year-old male patient was admitted to the internal
medicine polyclinic with complaints of high fever and malaise.
These, plus diffuse pain, had started 3 days before and became
increasingly severe. He had no history of diseases or medicine
use. In the physical examination, his auxiliary body tempera-
ture was 39 ◦C, and other systemic examinations were normal.
Table 1 – Test results of the patient.
Test 1st day 3rd day 
AST (U/L) 67 37 
ALT (U/L) 98 77.5 
LDH (U/L) 260 
CK (U/L) 149 
CRP (mg/dL) 2.4 1.74 
ESH (mm/h) 10 
WBC (×103/mm3/L) 3.73 5.35 
Neutrophils (%) 40.5 59 
Lymphocytes (%) 26.8 25 
Monocytes (%) 28 9.7 
HGB (g/dL) 16.7 15.9 
Platelets (×103/mm3/L) 123 124 
Parvovirus B19 IgM 76.9 positive 
Parvovirus B19 IgG 11.8 
Herpes Simplex Type1 IgM 
Herpes Simplex Type1 IgG 
Herpes Simplex Type2 IgM 
Herpes Simplex Type2 IgG 
Ebstein–Barr virus VCA-IgM 
Ebstein–Barr virus VCA-IgG 
ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C-r
rates; WBC, white blood cell; HGB, hemoglobin. 0 1 5;5 5(2):185–188
The laboratory tests revealed increased levels of alanine
aminotransferase (ALT), aspartate aminotransferase (AST),
and C-reactive protein (CRP). Leukopenia, thrombocytopenia,
and monocytosis were found in his hemogram (Table 1). A
slight increase in monocytes was found in his peripheral
blood smear. Blood culture taken during his high fever period
showed no growth. Heterophile antibody (monospot) was neg-
ative.
Maculopapular rashes developed under both knees but his
fever decreased within the next 2 days. B19 antibody IgM
tested positive, and thus B19 was considered to be the cause
of the rashes. On the third day of the disease, arthralgia devel-
oped in both ankles, and also in both hands. On the sixth day,
the rashes remitted, replaced by pain in both calves so severe
that it prevented him from walking.
In the investigations performed for the follow-up, AST, ALT
and creatine kinase (CK) were found to have decreased to
within normal ranges, but CRP and erythrocyte sedimentation
rates (ESH) had increased (Table 1). The patient was hospi-
talized, and naproxen sodium 1100 mg/day was initiated. The
bilateral cruris MRI taken due to continuing severe pain on his
bilateral calf muscles revealed thickening and edema in both
gastrocnemius and the semimembranosus muscle group, an
increased signal in T2, and an edematous appearance. The
minimal contrast involvement in the post-contrast series was
considered to be myositis (Fig. 1). Follow-up on the 10th day
of the treatment revealed reduced pain, and ESH and CRP had
returned to within their normal ranges.Discussion
B19 is common worldwide, and the seroprevalence increases
with age, so that 15% of preschool children, 50% of younger
8th day 10th day 17th day Normal range
28 30 16 10–50
57.7 34 15–38
254 246 190 0–225
52 51 39–308
1.76 5.9 0–0.5
42 90 <15
6 7.02 3.8–10
55 40 50–80
29 43 10–48
12 12.7 2–10
14.3 14.1 13–17.5
274 321 142–424
<9 U
<9 U
0.27 <1.1 ratio
>200 <22 RU
0.16 <1.1
<2 <22 RU/mL
0.34 <1.1
84.86 <22 RU/mL
eactive protein; CK, creatine kinase; ESH, erythrocyte sedimentation
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Neurology. 1999;53:2127–31.Fig. 1 – Both lower limbs’ MRI  images of the patient.
dults and about 85% of the elderly show serologic evidence
f past infection.2 This infectious disease is generally seen
uring childhood, but rarely in adults. Laboratory diagnosis
f B19 can be performed using serology, PCR, histopatho-
ogic examination and immunohistochemistry.2 The precise
iagnosis of recent or past infection with B19 depends on
he use of enzyme immunoassays to detect anti-B19 IgM
nd IgG in plasma. To conﬁrm acute B19 infection, IgM
ntibodies must be detected in plasma or serum. These anti-
odies are synthesized approximately 7–10 days after the
igh-titer viremia.4 B19 IgG appears shortly after IgM and
ersists lifelong with slowly decreasing titers unless boosted
y subsequent encounters with the virus. The clinical sig-
iﬁcance of different serum-titers of B19 DNA is not fully
stablished. In healthy individuals with acute B19 infec-
ion, viral titers as high as 1012 gEq/mL are detectable in
lood.3,4
Benign acute myositis is a self-recovering [benign] condi-
ion characterized by acute bilateral calf pain and difﬁculty
n walking that usually develops in school-age children after
hey have recovered from viral infections. It was ﬁrst recog-
ized in 1957 by Lundberg in 74 pediatric subjects.5,6 Myositis
ases coincide with dermatomyositis and systemic lupus ery-
hematosus after Parvovirus B19 infection in adults.7 Although
he most common viral causes of acute myositis are Inﬂuenza
, B (including the H1N1 virus) and Coxsackievirus viruses
n children, no case report was found about B19 associated
ith benign acute childhood myositis.8 However, there is
ne case report about myofacitis associated with B19 in a
ealthy adult.9 But, to our knowledge, literature reports no
ases about myositis associated with B19 in an adult. As we
now B19 infection occurs especially in transplant patients,
atients with systemic diseases and immunocompromised
atients.4 In our case, although there was no history of ill-
ess and drug intake, history of intense pace of work, intense
tress and a 12-h trip might have a negative impact on
mmune resistance and may cause myositis associated with
19. 5;5 5(2):185–188 187
In our patient, clinical and laboratory ﬁndings, magnetic
resonance imaging and response to therapy support the
diagnosis of acute myositis. The expected increased sedi-
mentation and CRP were found; however, the CK level had
not increased in our patient. The absence of increased CK
levels may lead to confusion. From the patient’s laboratory
follow-up, we could see that CK level was three times higher
in the ﬁrst period. But CK level was normal in every period
of the disease. Although most patients with inﬂammatory
myopathies present with increased creatine kinase levels,
reported series include some patients with normal creatine
kinase levels.9–11 In these cases, even though myopathy was
diagnosed by methods such as biopsy and MRI, CK levels
were normal. And concrete evidence was not submitted to
explain this situation. In an article presenting seven patients
with myositis, a lack of creatine kinase elevation in patients
with myositis was found to be a poor prognostic sign.10 Our
case had a benign course and clinical ﬁndings improved
quickly.
Despite the similarity with childhood benign acute myosi-
tis cases, our case was thought to be interesting because it
was in an adult with no increased CK level. In patients who
present with fever, rash on the legs, and myositis (such as
in our case), viral infections such as B19 should be kept in
mind.
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